Answer
No. A risk to the infant cannot be excluded, so breastfeeding is not recommended during treatment or for two weeks afterwards.
Sources for this answer
- Nilotinib 150mg Hard Capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.